NCT00077181 2013-01-24
3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
1 trialsPhase 1 × Leukemia, Myeloid, Accelerated Phase × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all